Welcome to the Lymphoma Clinical Roadmap chaired by Dr. Christopher R. Flowers and Dr. Judith Trotman. The Lymphoma Roadmap is a free to access educational curriculum featuring presentations from world leading experts in their field. Every month we will have guest speakers presenting findings on a hot topic and the chairs will join to participate in a debate and question and answers session to dive deep into the subject.

Please register below to get free access to the content and to receive the monthly webinar direct to your email

Co-chair

Christopher R. Flowers, MD, M.S.

MD Anderson Cancer Centre, Houston, Texas

Christopher R. Flowers, MD, is Professor and Chair of the Department of Lymphoma and Myeloma at MD Anderson Cancer Center. He has focused on specialized care for patients with lymphoid malignancies.

Co-chair

Judith Trotman, MBChB, FRACP, FRCPA

Concord Hospital, Sydney

Professor Judith Trotman is Head of the Hematology Department, Concord Repatriation General Hospital, University of Sydney, AU. An active clinician researcher she has particular expertise in the management of lymphoid malignancies.

SCHEDULE Roadmap Faculty & Topics

January

Loretta Nastoupil

MD Anderson Cancer Center, Texas

MD Anderson Cancer Center, Texas

Clinical Management and Advances in Chimeric Antigen Receptor T-cell (CAR T) therapy for lymphomas

Catherine Thieblemont

Hôpital Saint-Louis, Paris

Hôpital Saint-Louis, Paris

Updates in Marginal Zone Lymphoma

February

Ranjana Advani

Stanford University School of Medicine

Stanford University School of Medicine

Risk Stratification and Therapeutic Approach for First line Hodgkin Lymphoma

Brad Kahl

Washington University School of Medicine

Washington University School of Medicine

Recent advances in lymphoma clinical trials

March

Pamela Allen

Winship Cancer Institute

Winship Cancer Institute

Best practices and Recent Advances in Cutaneous T-cell Lymphoma

Paolo Strati

MD Anderson Cancer Center, Texas

MD Anderson Cancer Center, Texas

What’s relevant now in first line follicular lymphoma

April

Elizabeth Brem

University of California Irvine

University of California Irvine

New Clinical Advances and Research Questions in the Management of Older Patients with Diffuse Large B-cell Lymphoma (DLBCL)

Kara Kelly

Roswell Park Comprehensive Cancer Center

Roswell Park Comprehensive Cancer Center

Caring for Adolescent and Young Adult patients with Lymphoma

May

Chan Cheah

Clinical Professor, UWA Medical School, Internal Medicine

Clinical Professor, UWA Medical School, Internal Medicine

Risk Stratification and Therapeutic Approach for Relapsed Follicular Lymphoma

Kami Maddocks

MD Professor of Clinical Internal Medicine Director of Lymphoma Program The Ohio State University The James Comprehensive Cancer Center Department of Internal Medicine Division of Hematology

The Ohio State University,
The James Comprehensive Cancer Center

Approaches for First Line Management of Diffuse Large B cell Lymphoma (DLBCL)

June

Chelsea Pinnix

MD Anderson Cancer Center, Texas

MD Anderson Cancer Center, Texas

What’s New in Radiation Therapy in Lymphoma

Jason Westin

MD Anderson Cancer Center, Texas

MD Anderson Cancer Center, Texas

Incorporating new agents into regimens for aggressive B-cell lymphomas

July

Alex Herrera

City of Hope, Duarte

City of Hope, Duarte

Next Steps in Combination Therapies for Relapsed Hodgkin Lymphoma

Marek Trneny

Charles University Hospital, Prague

Charles University Hospital, Prague

First line therapy for Mantle Cell Lymphoma

August

Neha Mehta-Shah

Washington University School of Medicine

Washington University School of Medicine

Targeted Therapies for T-cell Lymphomas

Michael Wang

MD Anderson Cancer Center, Texas

MD Anderson Cancer Center, Texas

Novel approaches for relapsed Mantle Cell Lymphoma

September

Ahmed Sairah

MD Department of Lymphoma - Myeloma, Division of Cancer Medicine

Anderson Cancer Centre

Novel strategies for Enhancing CAR T cell therapy

Eliza Hawkes

Olivia Newton-John Cancer Centre, Melbourne

Olivia Newton-John Cancer Centre, Melbourne

Predictive and prognostic biomarkers in lymphoma

October

Ore Odejide

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Improving quality of life and quality of care for patients with lymphoma

Judith Trotman, MBChB, FRACP, FRCPA

Concord Hospital, Sydney

Concord Hospital, Sydney

Approaches to Imaging in Aggressive Lymphomas

November

Barbara Pro

Robert H. Lurie Comprehensive Cancer Center of Northwestern

The Herbert Irving Comprehensive Cancer Center, Columbia University, New York.

Advances in T-cell lymphomas

Jessica Okosun

Barts Cancer Institute, London

Barts Cancer Institute, London

Translating discoveries in follicular lymphoma into practice

December

Sarah Rutherford

Weill Cornell Medicine

Weill Cornell Medicine

Diagnostic and Management Approaches for High-Risk Aggressive B-cell Lymphomas

Laurie Sehn

The University of British Columbia

The University of British Columbia

What’s new for relapsed lymphoma

End of the year discussion

Christopher R. Flowers, MD, M.S.

MD Anderson Cancer Centre, Houston, Texas

Judith Trotman, MBChB, FRACP, FRCPA

Concord Hospital, Sydney

Ahmed Sairah

MD Department of Lymphoma - Myeloma, Division of Cancer Medicine

Loretta Nastoupil

MD Anderson Cancer Center, Texas

Laurie Sehn

The University of British Columbia